Characteristics of the study participants for continuous variables. حسب Aroon La-up (14095691)

الموضوعات:

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  حسب Claire M. Douglas (21238238)

الموضوعات:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  حسب Claire M. Douglas (21238238)

الموضوعات:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. حسب Claire M. Douglas (21238238)

الموضوعات:

Participant demographic and clinical characteristics. حسب Claire M. Douglas (21238238)

الموضوعات:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... حسب Claire M. Douglas (21238238)

الموضوعات:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... حسب Claire M. Douglas (21238238)

الموضوعات:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... حسب Claire M. Douglas (21238238)

الموضوعات:

HDECO: A method for Decreasing energy and cost by using virtual machine migration by considering hybrid parameters حسب Arash GhorbanniaDelavar (22563696)

"…</p><p dir="ltr">Compared to the ECIB algorithm and previous approaches, HDECO achieved significant improvements:</p><ul><li><b>Up to 10% reduction in energy consumption</b></li><li><b>8% decrease in overall execution cost</b></li><li><b>Better real execution time and fewer unnecessary migrations</b></li></ul><p dir="ltr">This makes HDECO an effective and lightweight solution for instance-intensive cloud workflows.…"

The SPAM fitted on empirical data. حسب Kimmo Sorjonen (495847)

The effect of pre-RT D-dimer levels on post-RT changes in D-dimer levels and on survival rates. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

ROC curve according to their D-dimer values in patients with PFS ≥ 1 year and those with PFS < 1 year. p < 0.001 (95% CI: 4-21). حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Kaplan Meier curves of OS and PFS according to RT and/or CRT response. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Univariate and multivariable analyses for progression free survival. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Kaplan Meier curves of OS and PFS according to different pre-RT different D-dimer values. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Univariate and multivariable analyses for OS. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Characteristics of LC patients. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Decision curve analysis according to t D-dimer values in patients with OS ≥ 1 year and those with OS < 1 year. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Kaplan Meier curves of OS and PFS according to d-dimer values comparing OS rates between patients with D-dimer levels ≤ 0.3 µg/mL and those with levels > 0.3 µg/mL. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

ROC curve according to their D-dimer values in patients with OS ≥ 1 year and those with OS < 1 year. p < 0.001 (95% CI: 6-24). حسب Huriye Senay Kiziltan (22298378)

الموضوعات: